XML 42 R28.htm IDEA: XBRL DOCUMENT

Revenues (Tables)

9 Months Ended

Sep. 30, 2020

Revenues

Schedule of disaggregated revenue

As discussed in Note 2, revenues are recognized under guidance within ASC 606 and ASC 808. The following table presents our disaggregated revenue for the periods presented (in thousands):


		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2020			2019			2020			2019
JAKAFI revenues, net		$	487,783		$	433,387		$	1,420,968		$	1,218,504
ICLUSIG revenues, net			26,380			20,611			76,426			65,640
PEMAZYRE revenues, net			8,089			—			11,875			—
Total product revenues, net			522,252			453,998			1,509,269			1,284,144
JAKAVI product royalty revenues			68,306			58,440			190,856			160,906
OLUMIANT product royalty revenues			28,647			21,643			79,924			56,820
TABRECTA product royalty revenues			1,438			—			2,144			—
Total product royalty revenues			98,391			80,083			272,924			217,726
Milestone and contract revenues			—			17,500			95,000			77,500
Total revenues		$	620,643		$	551,581		$	1,877,193		$	1,579,370